ANTHRACYCLINES - CARDIOTOXICITY AND ITS PREVENTION

被引：43

作者：

HALE, JP ^{[1
]}

LEWIS, IJ ^{[1
]}

机构：

[1] ST JAMES UNIV HOSP,REG CTR PAEDIAT ONCOL,LEEDS LS9 7TF,W YORKSHIRE,ENGLAND

来源：

ARCHIVES OF DISEASE IN CHILDHOOD | 1994年 / 71卷 / 05期

关键词：

D O I：

10.1136/adc.71.5.457

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

[No abstract available]

引用

页码：457 / 462

页数：6

共 63 条

[31] REDUCTION OF DOXORUBICIN CARDIOTOXICITY BY PROLONGED CONTINUOUS INTRAVENOUS-INFUSION [J].

LEGHA, SS ;

BENJAMIN, RS ;

MACKAY, B ;

EWER, M ;

WALLACE, S ;

VALDIVIESO, M ;

RASMUSSEN, SL ;

BLUMENSCHEIN, GR ;

FREIREICH, EJ .

ANNALS OF INTERNAL MEDICINE, 1982, 96 (02) :133-139

[32] LATE CARDIAC EFFECTS OF DOXORUBICIN THERAPY FOR ACUTE LYMPHOBLASTIC-LEUKEMIA IN CHILDHOOD [J].

LIPSHULTZ, SE ;

COLAN, SD ;

GELBER, RD ;

PEREZATAYDE, AR ;

SALLAN, SE ;

SANDERS, SP .

NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (12) :808-815

[33] EARLY DETECTION OF DOXORUBICIN CARDIOTOXICITY - INTEREST OF DOPPLER ECHOCARDIOGRAPHIC ANALYSIS OF LEFT-VENTRICULAR FILLING DYNAMICS [J].

MARCHANDISE, B ;

SCHROEDER, E ;

BOSLY, A ;

DOYEN, C ;

WEYNANTS, P ;

KREMER, R ;

POULEUR, H .

AMERICAN HEART JOURNAL, 1989, 118 (01) :92-98

[34] POTENTIATION OF DOXORUBICIN CYTOTOXICITY BY (+)-1,2-BIS-(3,5-DIOXOPIPERAZIN-1-YL) PROPANE (ICRF-187) IN HUMAN LEUKEMIC HL-60 CELLS [J].

MONTI, E ;

SINHA, BK .

CANCER COMMUNICATIONS, 1990, 2 (04) :145-149

[35] ADRIAMYCIN - ROLE OF LIPID PEROXIDATION IN CARDIAC TOXICITY AND TUMOR RESPONSE [J].

MYERS, CE ;

MCGUIRE, WP ;

LISS, RH ;

IFRIM, I ;

GROTZINGER, K ;

YOUNG, RC .

SCIENCE, 1977, 197 (4299) :165-167

[36] PROSPECTIVE EVALUATION OF DOXORUBICIN CARDIOTOXICITY BY REST AND EXERCISE RADIONUCLIDE ANGIOGRAPHY [J].

PALMERI, ST ;

BONOW, RO ;

MYERS, CE ;

SEIPP, C ;

JENKINS, J ;

GREEN, MV ;

BACHARACH, SL ;

ROSENBERG, SA .

AMERICAN JOURNAL OF CARDIOLOGY, 1986, 58 (07) :607-613

[37] ENDOMYOCARDIAL BIOPSY TO MONITOR ANTHRACYCLINE THERAPY IN CHILDREN [J].

PEGELOW, CH ;

POPPER, RW ;

DEWIT, SA ;

KING, OY ;

WILBUR, JR .

JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (05) :443-446

[38]

PRAGA C, 1991, CLINICAL MEASUREMENT IN DRUG EVALUATION, P131

[39]

RAJAGOPALAN S, 1988, CANCER RES, V48, P4766

[40] CORRECTED QT INTERVAL PROLONGATION IN ANTHRACYCLINE-TREATED SURVIVORS OF CHILDHOOD-CANCER [J].

SCHWARTZ, CL ;

HOBBIE, WL ;

TRUESDELL, S ;

CONSTINE, LC ;

CLARK, EB .

JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (10) :1906-1910

← 1 2 3 4 5 6 7 →